A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors. (2010)

First Author: Evers B
Attributed to:  The iBAC genomic DNA expression library funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-09-2434

PubMed Identifier: 20008842

Publication URI: http://europepmc.org/abstract/MED/20008842

Type: Journal Article/Review

Volume: 16

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 1

ISSN: 1078-0432